| Symbol | ATLN |
|---|---|
| Name | ATLANTIC INTERNATIONAL CORP. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | - |
| Address | 07632 United States NJ 270 Sylvan Avenue Suite 2230 |
| Telephone | (201) 899-4470 |
| Fax | — |
| — | |
| Website | https://seqll.com/ |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | RBSM LLP; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001605888 |
| Description | SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The companys True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justices Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support. Additional info from NASDAQ: Additional info from OTC: |
New Form 424B3 - ATLANTIC INTERNATIONAL CORP. <b>Filed:</b> 2026-04-08 <b>AccNo:</b> 0001213900-26-041282 <b>Size:</b> 437 KB
Read moreNew Form 424B3 - ATLANTIC INTERNATIONAL CORP. <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001213900-26-039326 <b>Size:</b> 407 KB
Read moreNew Form NT 10-K - ATLANTIC INTERNATIONAL CORP. <b>Filed:</b> 2026-04-01 <b>AccNo:</b> 0001605888-26-000009 <b>Size:</b> 29 KB
Read more(99% Neutral) ATLANTIC INTERNATIONAL CORP. (ATLN) Announces Business Combination
Read moreNew Form DEL AM - ATLANTIC INTERNATIONAL CORP. <b>Filed:</b> 2026-03-24 <b>AccNo:</b> 0001213900-26-033548 <b>Size:</b> 8 KB
Read more